SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending after an unexpected after-hours dip following its Q4 earnings report, which, despite beating revenue and EPS estimates, has left many investors confused and disappointed. Community discussion is split, with some seeing the pullback as a manipulated opportunity for a long-term hold, citing strong ad revenue growth and the Warner Bros Discovery acquisition as future catalysts, while others express concern over cautious Q1 guidance and the deal's financial implications.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending with intense community debate as fears of a "crypto winter" intensify, driven by concerns over geopolitical tensions like tariff threats and potential impacts on institutional demand. Traders are actively discussing critical support levels and whether the current downturn represents a significant market correction or a temporary shakeout of over-leveraged positions.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending after Chairman Ryan Cohen disclosed an additional purchase of 500,000 shares, boosting his stake and signaling confidence. The community is buzzing with speculation that Cohen's move indicates a potential bottom and could be a catalyst for another significant price run, especially amid ongoing discussions about market manipulation and a possible return of "Roaring Kitty".

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending sharply lower as markets react to escalating geopolitical tensions over Greenland, which has spurred fear of broad tariffs and an unwind of international capital flows. This immediate catalyst has triggered widespread community debate, fueling predictions of a deeper market correction while others view the pullback as a significant buying opportunity. Discussions are intensely focused on whether current global political rhetoric will continue to drive significant market volatility or if a swift rebound is imminent.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to positive Phase 1 clinical trial data for its atopic dermatitis drug, soquelitinib, which demonstrated strong efficacy and a favorable safety profile. The community is buzzing about the drug's potential as an oral, best-in-class therapy in a massive market, sparking speculation of partnerships or a buyout. However, concerns over potential share dilution to fund future, more expensive trials are also widely discussed, leading to varied sentiment.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF (DIA) is actively trending as heightened geopolitical tensions, specifically surrounding renewed tariff threats from the Trump administration related to Greenland and European allies, are sparking fears of a global trade war. This has led to a notable market pullback and widespread discussion among investors about potential economic instability and the future of international trade relations. The community is keenly observing for further developments, including reactions from global markets and central banks, as these concerns remain a primary focus.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is actively discussed following a Morgan Stanley downgrade and concerns over perceived market manipulation, with many in the community viewing the suppressed price as a significant buying opportunity. Investors are highlighting its attractive dividend yield, the strategic company split planned for unlocking value, and new leadership as key factors for a potential turnaround. As a consumer staple, KHC is also drawing attention as a defensive play amidst broader market shifts.

Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. It operates through the following geographical segments: United States, Germany, Australia, Switzerland, and Sweden. The company was founded in 1999 and is headquartered in Eagan, MN.

Anteris Technologies Global Corp.

Anteris Technologies Global

Anteris Technologies Global is trending following a strategic private placement with Medtronic and the enrollment of the first patients in its pivotal PARADIGM trial for the DurAVR heart valve. This dual news has ignited intense community discussion, with many viewing Medtronic's involvement as a strong validation and anticipating significant appreciation. However, others express concern over potential dilution from the associated public offering despite the positive developments.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending lower as market sentiment reacts sharply to former President Trump's threats of new tariffs against European allies concerning Greenland. This has ignited a lively debate within the community, with some anticipating a deeper market correction amid broader bond market jitters, while others expect a "buy the dip" rebound, confident in the underlying strength of the tech sector despite geopolitical noise.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is trending amid recent contract wins with the U.S. Army for AI-driven logistics and the Department of Health and Human Services to build a national health data platform. This federal traction is sparking debate, with bulls citing high short interest and perceived deep value as catalysts for a potential squeeze. However, skeptics remain vocal about the company's revenue challenges and ongoing unprofitability despite the burgeoning AI sector.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ionis Pharmaceuticals, Inc. $IONS Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. decreased its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 17.9% during the 3rd quarter, according to its most recent 13F filing...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) have earned an average rating of "Moderate Buy" from the twenty-two ratings firms that are presently covering the company...

Ionis Pharmaceuticals (NASDAQ:IONS) Shares Pass Above 200 Day Moving Average - Should You Sell?

Ionis Pharmaceuticals (NASDAQ:IONS) Stock Crosses Above 200 Day Moving Average - Should You Sell...

Ionis well-positioned for continued momentum and substantial value creation in 2026 with two new independent launches and several pivotal data readouts

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced highlights from the Company's 2025 achievements and provided additional updates on key milestones expected in 2026. Ionis will provide a...

Insider Selling: Ionis Pharmaceuticals (NASDAQ:IONS) EVP Sells 44,199 Shares of Stock

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) EVP Shannon Devers sold 44,199 shares of the firm's stock in a transaction dated Wednesday, January 7th. The stock was sold at an average...

GSK's Chronic Hepatitis B Drug Meets Goals in Two Late-Stage Studies

GSK's bepirovirsen hit primary endpoints in two phase III trials, boosting hopes for a functional cure in chronic hepatitis B patients.

Ionis Pharmaceuticals (NASDAQ:IONS) EVP Eric Swayze Sells 23,463 Shares

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) EVP Eric Swayze sold 23,463 shares of the stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average...

Ionis partner GSK announces positive topline results from B-Well 1 and B-Well 2 Phase 3 studies for bepirovirsen, a potential first-in-class medicine for chronic hepatitis B

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced positive results from two pivotal Phase 3 studies, B-Well 1 and B-Well 2, evaluating the safety and efficacy of bepirovirsen, an...

Eric Swayze Sells 23,463 Shares of Ionis Pharmaceuticals (NASDAQ:IONS) Stock

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) EVP Eric Swayze sold 23,463 shares of the company's stock in a transaction on Friday, January 2nd. The stock was sold at an average price...

Ionis to present at 44th Annual J.P. Morgan Healthcare Conference

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference at...

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Ionis Pharmaceuticals Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

IONS
Ionis Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest IONS News

IONSIonis Pharmaceuticals Inc